Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | K25M5 | IM / RL |
Patient inadvertently received and additional dose of beyfortus, it was not caught prior to admiration that the child had received a dose at the 1-month visit. Child has not had any known reaction to extra dose of medication.
None
Eczema
Pepcid, Mylicon, Beyfortus
NKA